CN Patent

CN104288092A — 拉坦前列素滴眼剂

Assigned to Sunshine Lake Pharma Co Ltd · Expires 2015-01-21 · 11y expired

What this patent protects

本发明公开了一种含有拉坦前列素的原位凝胶滴眼剂，所述滴眼剂含有活性成分拉坦前列素，抗氧剂，表面活性剂，凝胶基质，粘附剂，pH调节剂以及任选的防腐剂；所述滴眼剂稳定性良好，可避免由于容器的吸附而使药物浓度降低，解决了普通滴眼液在眼部药物滞留时间短，生物利用度低的缺陷。

USPTO Abstract

本发明公开了一种含有拉坦前列素的原位凝胶滴眼剂，所述滴眼剂含有活性成分拉坦前列素，抗氧剂，表面活性剂，凝胶基质，粘附剂，pH调节剂以及任选的防腐剂；所述滴眼剂稳定性良好，可避免由于容器的吸附而使药物浓度降低，解决了普通滴眼液在眼部药物滞留时间短，生物利用度低的缺陷。

Drugs covered by this patent

Patent Metadata

Patent number
CN104288092A
Jurisdiction
CN
Classification
—
Expires
2015-01-21
Drug substance claim
No
Drug product claim
No
Assignee
Sunshine Lake Pharma Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.